Clinical Trials Logo

Positive clinical trials

View clinical trials related to Positive.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03251352 Recruiting - Leukemia Clinical Trials

TKI Discontinuation in CML Patients of China

TFR_china
Start date: March 1, 2017
Phase:
Study type: Observational

The primary objective of this study is to describe the maintenance of the molecular remission after tyrosine kinase inhibitor (TKI) disconnection in chronic myeloid leukaemia (CML) patients in China in the real-world clinical practice setting. This is a post-marketing, non-interventional, single-arm, prospective registry study in adult patients with chronic phase (CP) and accelerated phase (AP) in China. Patients will be recruited consecutively from the study sites during the enrollment period. The enrolled patients will be undertaking TKI discontinuation under the conditions of informed consent and frequent monitoring according to the clinical guideline.